Published: 2016-12-30

Antihypertensive drug use and blood pressure control among in-patients with hypertension in a Nigerian tertiary healthcare centre

Aduragbenro DA Adedapo, Waheed Adeola Adedeji, Abiola Muhammad Adeosun, Japhet Olaremi, Cecelia Kehinde Okunlola


Background: Hypertension is a risk factor for coronary heart disease, renal failure, stroke and death if not detected early and treated appropriately. Pattern of drug use provides information on quality of use by comparing the use of drugs with recommended guidelines. This study assessed the pattern of drug use and blood pressure (BP) control among in-patients with hypertension.

Methods: This was a retrospective study carried out on hospitalised patients with hypertension in a tertiary health care centre. Patients’ demographic data, clinical findings, and prescription pattern were documented. The average of three consecutive blood pressure (BP) readings prior to discharge was used to assess BP control.

Results: Of 162 patients, 27 (16.7%) and 62 (38.3%) patients were admitted with moderate and severe hypertension respectively. One hundred and fifty three (94.4%) patients were on antihypertensive drugs, out of which 32 (20.9%) had monotherapy, 62 (40.5%) had two antihypertensive combinations, 59 (38.6%) had three or more antihypertensive combinations. The order of antihypertensive drugs use was calcium channel blocker (CCBs) 114 (70.4%), angiotensin converting enzyme inhibitors (ACEIs) 100 (61.7%), diuretics 98 (60.5%), centrally acting agent 24 (14.8%), angiotensin receptor blockers (ARBs) 8 (4.9%), and β-blockers (BB) 8 (4.9%). Blood pressure control was achieved in 48.8% of the patients’ population. Factors that negatively influence blood pressure control were presence of co-morbidity (p=0.027). Factor that positively influence blood pressure control was dietary lifestyle modification (p=0.009).

Conclusions: The use of antihypertensive drugs was in accordance with treatment guidelines, but blood pressure was achieved in 48.8% of patients.


Antihypertensive drugs, BP, Drug use, Hypertension

Full Text:



WHO. Introduction to drug utilization research. Geneva: WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, 2003.

WHO. The selection of essential drugs. World Health Organization, 1977.

Himmelfarb CD, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, et al. Evidence-based guideline for the management of high blood pressure in adults report. From the panel members appointed to the eighth joint national committee (JNC8). JAMA. 2013;E1-E14.

Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World journal of cardiology. 2006;4:327-40.

Ekere AU, Yellowe BE, Umune S. Mortality patterns in the accident and emergency department of an urban hospital in Nigeria. Nigerian Journal of Clinical Practice. 2005;8:14-8.

Becket NS, Peter R, Fletcher AE, Staessen JA, Liu L, Damitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Eng J Med. 2008;358:1887-98.

Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, et al. Management of high blood pressure in blacks an update of the international society on hypertension in blacks (ISHIB) consensus statement. Hypertension. 2010;56:780-800.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-71.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. The New England journal of medicine. 2000;342:145-53.

Gu Q, Ram RP, Dillon C, Vicki. Antihypertensive medication use among us adults with hypertension. Circulation. 2006;113:213-21.

Cheung BMY, Wong YL, Lau CP. Queen mary utilization of antihypertensive drugs study: use of antihypertensive drug classes in the hypertension clinic 1996-2004. B J clinical Pharmacol. 2005;60:90-7.

Maepe LM, Outhoff K. Hypertension in goldminers. SAMJ. 2012;102:30-3.

Tamuno I, Babahani M. Blood pressure control amongst hypertensive patients in a tertiary health care facility in Nothern Nigeria. Res J Med Sci. 2012;6:26-32.

Yusuff KB, Balogun O. Physician’s prescribing of antihypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci. 2005;8:235-42.

Salako BL, Ajose FA, Lawani E. Blood pressure control in a population where antihypertensives are given free. East Afr Med J. 2003;80:529-31.

WHO collaborating centre for drug statistics methodology: guidelines for ATC classification and DDD assignment 2014. Oslo. 2013.

WHO/ISH. 2003 world health organization (WHO)/international society of hypertension (ISH) statement on management of hypertension. Journal of Hypertension. 2003;21:1983-92.

WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. WHO technical report series 854. Geneva: world health organization. 1995.

Buckley B, Shanahan E, Colwell N, Turgonyi E, Bramlage P, Perry, IJ. Blood pressure control in hypertensive patients in Irish primary care practices. J Clin Hypertens. 2009;11:432-440.

Cheung BMY, Ong KL, Man YB, Lam KS, Lau CP. Prevalence, awareness, treatment, and control of hypertension. United States national health and nutrition examination survey 2001-2002. J Clin Hypertens. 2006;8:93-8.

Brewster LM, Van-Montfrans GA, Kleijnem J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614-27.

Ukwe CV, Ubaka CM. Antihypertensive drug prescribing in a tertiary hospital in Eastern Nigeria. Tropical Journal of Pharmaceutical Research. 2012;11:297-305.

Oyati AI, Orogade AA, Danbauchi SS, Azuh PC. Awareness, treatment and control of hypertension among hypertensives in Zaria. Journal of Medicine in the Tropics. 2011;13:139-44.

Steyn K, Bradshaw D, Norman R, Laubscher R. Determinants and treatment of hypertension in South Africans: the first demographic and health survey. S Afr Med J. 2008:98;376-80.

Isezuo AS, Njoku CH. Blood pressure control among hypertensives managed in a specialized health care setting in Nigeria. Afr J Med Med Sci. 2003;32:65-70.

Sica DA. The African American study of kidney disease and hypertension (AASK) trial: what more have we learned? J Clin Hypertens. 2003;5:159-67.

Adedapo ADA, Sikuade O, Adeleke S, Okechukwu R. Drug utilization and blood pressure control in a population where anti hypertensives are given free: effect of policy change. Afr J Med Sc. 2012;41:349-56

Etuk E, Isezuo SA, Chika A, Akuche J, Ali M. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria. Annals of African Medicine. 2008;7:128-32.